December 17, 2025 06:41 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Indian Visa Application Centre in Dhaka shuts down early amid rising security concerns | Market update: Sensex tumbles 120 points, Nifty below 25,850 at closing bell | ‘Won’t apologise’: Prithviraj Chavan stands firm on controversial Operation Sindoor remark despite backlash | India summons Bangladesh High Commissioner after provocative 'seven sisters' remark | Amazon eyes $10 billion investment in OpenAI — a gamechanger for AI industry! | Goa nightclub fire horror: Luthra brothers brought back to India from Thailand, arrested | Messi chaos costs minister his job: Aroop Biswas resigns after Salt Lake Stadium fiasco | Bengal SIR draft list out: Around 58 lakh voters’ names dropped | Relief for Sonia, Rahul Gandhi as Delhi court refuses to act on ED chargesheet in National Herald case | Centre moves to replace MGNREGA with 'G Ram G', sets stage for winter session showdown

India maintains its supremacy over China in pharmaceuticals

| | Jul 05, 2016, at 06:21 pm
New Delhi, Jul 5 (IBNS): The Union Ministry of Commerce & Industry announced on Tuesday that India’s pharmaceutical (pharma) exports continued its lead over China in 2015.
While India’s pharma exports grew from US $11.66 billion to US $12.54 billion in 2015, up 7.55%, that of China increased from US $6.59 billion to US $6.94 billion, up 5.3%, during the same period. 
 
India moved ahead of China in all important markets such as the US, the European Union (EU) and Africa, the ministry said. 
 
India’s exports of pharma products to US jumped from US $3.84 billion to US $4.74 billion, up 23.4% against China’s pharma exports to US which moved from US $1.16 billion to US $1.34 billion, up 15% in the same period. 
 
India maintained its lead with growth in the EU and Africa recording exports of US $1.5 billion and US $3.04 billion, respectively, while China’s exports to the EU and Africa showed a declining trend in both the markets, the release said. 

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.